Privatizing Jerusalem or an Investigation into the City\u27s Future Legal Stakes

The purpose of this article is not to propose yet another normative version for Jerusalem\u27s future. Instead, I map out the major sovereignty-related issues that have traditionally preoccupied the literature on the subject, and argue that most of these issues have become moot following the latest rounds of Israeli-Palestinian negotiations. In response to this recent paradigm shift, I propose that international law scholarship should turn its attention to studying the politics of Jerusalem\u27s private sphere, a sphere so far dismissed as merely technical , yet also a sphere replete with such deep distributional stakes as to make it the primary arena for playing out power-relations in the city\u27s future. I conclude with critiquing recent proposals that privatization would play a constructive role in defusing political tensions associated with the future Jerusalem

Comparative Law: Problems and Prospects

This is an edited transcript of the closing plenary session of the XVIIIth International Congress of Comparative Law. The session took place on Saturday, July 31, 2010, in Washington, D.C., at the conclusion of the week-long congress, which is held quadrennially by the International Academy of Comparative Law (Acadimie Internationale de Droit Compare). The remarks were given in a mix of French and English, but for ease of reading the transcript is almost entirely in English

Comparative Law: Problems and Prospects

This is an edited transcript of the closing plenary session of the XVIIIth International Congress of Comparative Law. The session took place on Saturday, July 31, 2010, in Washington, D.C., at the conclusion of the week-long congress, which is held quadrennially by the International Academy of Comparative Law (Acadimie Internationale de Droit Compare). The remarks were given in a mix of French and English, but for ease of reading the transcript is almost entirely in English

Synthesis and Characterization of CuFe2O4 Nanoparticles Modified with Polythiophene: Applications to Mercuric Ions Removal

In this research, CuFe2O4 nanoparticles were synthesized by co-precipitation methods and modified by coating with thiophene for removal of Hg(II) ions from aqueous solution. CuFe2O4 nanoparticles, with and without thiophene, were characterized by x-ray diffraction (XRD), Field emission scanning electron microscopy (FESEM), energy dispersive x-ray (EDX), high-resolution transmission electron microscopy (HRTEM) and Brunauer–Emmett–Teller (BET). Contact time, adsorbent dose, solution pH, adsorption kinetics, adsorption isotherm and recyclability were studied. The maximum adsorption capacity towards Hg2+ ions was 7.53 and 208.77 mg/g for CuFe2O4 and CuFe2O4@Polythiophene composite, respectively. Modification of CuFe2O4 nanoparticles with thiophene revealed an enhanced adsorption towards Hg2+ removal more than CuFe2O4 nanoparticles. The promising adsorption performance of Hg2+ ions by CuFe2O4@Polythiophene composite generates from soft acid–soft base strong interaction between sulfur group of thiophene and Hg(II) ions. Furthermore, CuFe2O4@Polythiophene composite has both high stability and reusability due to its removal efficiency, has no significant decrease after five adsorption–desorption cycles and can be easily removed from aqueous solution by external magnetic field after adsorption experiments took place. Therefore, CuFe2O4@Polythiophene composite is applicable for removal Hg(II) ions from aqueous solution and may be suitable for removal other heavy metals

KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study

Abstract Background KLK10 exon 3 hypermethylation correlated to tumor-specific lack of KLK10 expression in cancer cell lines and primary tumors. In the present study we investigate the possible role of KLK10 exon 3 methylation in ovarian tumor diagnosis and prognosis. Results Qualitative methylation-specific PCR (MSP) results did not show statistically significant differences in patient group samples (normal and tumor) where all samples were positive only for the unmethylated-specific PCR except for two malignant samples that were either doubly positive (serous carcinoma) or doubly negative (Sertoli-Leydig cell tumor) for the two MSP tests. However, KLK10 exon 3 unmethylated PCR product concentration (ng/μl) showed statistically significant differences in benign and malignant patient group samples; mean ± SD (n): tumor: 0.077 ± 0.035 (14) and 0.047 ± 0.021 (15), respectively, p-value = 0.011; and normal: 0.094 ± 0.039 (7) and 0.046 ± 0.027 (6), respectively, p-value = 0.031. Moreover, ROC curve analysis of KLK10 exon 3 unmethylated PCR product concentration in overall patient group samples showed good diagnostic ability (AUC = 0.778; p-value = 0.002). Patient survival (living and died) showed statistically significant difference according to preoperative serum CA125 concentration (U/ml); median (n): 101.25 (10) and 1252 (5), respectively, p-value = 0.037, but not KLK10 exon 3 unmethylated PCR product concentration (ng/μl) in overall malignant patient samples; mean ± SD (n): 0.042 ± 0.015 (14) and 0.055 ± 0.032 (7), p-value = 0.228. Conclusion To the best of our knowledge, this is the first report on KLK10 exon 3 unmethylated PCR product concentration as potential early epigenetic diagnostic marker in primary ovarian tumors. Taken into account the limitations in our study (small sample size and semi-quantitative PCR product analysis) further studies are strongly recommended